The mechanism of action of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the control of haematopoietic stem cell proliferation

Cell Prolif. 1992 Nov;25(6):623-32. doi: 10.1111/j.1365-2184.1992.tb01464.x.

Abstract

The mechanism of action of the haemoregulatory tetrapeptide Acetyl-N-Ser-Asp-Lys-Pro (AcSDKP, M(r) = 487 amu), was investigated using an in vitro assay of a murine high proliferative potential colony-forming cell (HPP-CFC) which responds to proliferation regulators of the haematopoietic stem cell population. AcSDKP had no direct inhibitory effect on the number, or the proportion in S phase, of the committed granulocyte-macrophage progenitor (GM-CFC), or cycling HPP-CFC populations. However, AcSDKP blocked the action of a stimulator of haematopoietic stem cell proliferation, preventing the switching of quiescent HPP-CFC into cell cycle. It would appear that AcSDKP exerts its inhibitory haemoregulatory role indirectly, by preventing stimulator action on haematopoietic stem cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Bone Marrow
  • Cell Differentiation / drug effects
  • Cell Division / drug effects
  • Cells, Cultured / drug effects
  • Hematopoietic Stem Cells / drug effects*
  • Mice
  • Mice, Inbred CBA
  • Molecular Sequence Data
  • Oligopeptides / pharmacology*

Substances

  • Oligopeptides
  • goralatide